Norvasc (Amlodipine)

Amlodipine, the active ingredient in Norvasc, is a calcium channel blocker presented as a tablet for oral use. It lowers blood pressure and relieves chest pain by relaxing vascular smooth muscle, and is indicated for essential hypertension and chronic stable angina in adult patients.

GNH USA supplies Norvasc as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing quality‑assured products that meet EU regulatory standards. The company ensures consistent batch release, robust distribution controls, and compliance with Good Distribution Practice for global markets.

Norvasc (amlodipine) is a calcium channel blocker used to manage cardiovascular conditions.

- Essential hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Chronic stable angina: improves exercise tolerance and decreases the frequency of angina episodes. - Vasospastic (Prinzmetal) angina: prevents coronary artery spasm and associated chest pain.

Amlodipine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Peripheral edema: swelling of the ankles or feet. - Headache: mild to moderate intensity. - Flushing: sensation of warmth and redness. - Dizziness or light‑headedness. - Fatigue or general weakness. - Palpitations: awareness of heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Myocardial infarction: rare but possible in high‑risk patients. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, pruritus, or angioedema. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac conduction abnormalities: heart block or arrhythmias.

Before initiating therapy, clinicians should consider several safety aspects.

- Blood pressure monitoring: ensure adequate control and avoid excessive hypotension. - Hepatic impairment: dose adjustment may be required in moderate to severe liver disease. - Concomitant antihypertensives: watch for additive blood‑pressure‑lowering effects. - Heart failure: monitor for worsening peripheral edema. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amlodipine can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): may increase amlodipine plasma levels. - Simvastatin >20 mg: increased risk of statin‑related myopathy. - Grapefruit juice: can raise amlodipine concentrations.

Moderate Interactions (Monitor Closely):\n- Other antihypertensives (e.g., ACE inhibitors, beta‑blockers): additive hypotensive effect. - Diuretics: may enhance blood‑pressure reduction and electrolyte shifts. - Digoxin: monitor serum levels as amlodipine may affect renal clearance.